Related Experiment Video
Updated: Aug 12, 2025

10:10
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
Published on: November 2, 2018
9.3K
ADVANTAGES OF OPTICAL COHERENCE TOMOGRAPHY AS A HIGH DYNAMIC RANGE IMAGING MODALITY IN SUBRETINAL HYPERREFLECTIVE
Santiago Montolío-Marzo1, Roberto Gallego-Pinazo2, Elena Palacios-Pozo1,2
1FISABIO Ophthalmology Medical (FOM), Valencia, Spain; and.
Retina (Philadelphia, Pa.)
|February 2, 2023
Summary
High dynamic range optical coherence tomography imaging helps classify subretinal hyperreflective material (SHRM) in age-related macular degeneration. SHRM reflectivity impacts visual acuity and outer retinal layer integrity, suggesting its prognostic value.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Subretinal hyperreflective material (SHRM) is a key feature in neovascular age-related macular degeneration (nAMD).
- Accurate characterization of SHRM is crucial for understanding disease progression and treatment response.
Purpose of the Study:
- To evaluate the utility of high dynamic range optical coherence tomography (HDR-OCT) in characterizing SHRM.
- To correlate SHRM characteristics with visual acuity outcomes and structural changes in nAMD patients.
Main Methods:
- Retrospective review of OCT images from nAMD patients with SHRM.
- Classification of SHRM into hyperreflective (HyperR), isoreflective, and hyporeflective based on HDR-OCT.
- Assessment of SHRM changes, visual acuity, and fluid presence over 12 months.
Main Results:
- SHRM reflectivity varied, with hyporeflective SHRM disappearing fastest and HyperR SHRM persisting.
- Hyporeflective SHRM was associated with greater visual acuity improvement.
- Outer retinal layers were more frequently disrupted in the HyperR SHRM group.
Conclusions:
- HDR-OCT effectively classifies SHRM based on reflectivity, correlating with distinct clinical and structural outcomes.
- SHRM classification using HDR-OCT may serve as a prognostic biomarker in nAMD.

